Jaguar Health raises $3.45M via convertible notes; CEO & insiders participate

Jaguar Health, Inc.

$3.448M aggregate principal convertible notes at 6% interest, 3-month maturity, convertible into common stock at ~$5.54/share.
Insiders (CEO Conte, CFO, board members) purchase $535K of notes, also receive warrants at $5.43 exercise price.
Warrants exercisable immediately, expire in 5 years; up to 622,598 warrant shares plus 622,598 conversion shares.
Proceeds for working capital; H.C. Wainwright placement agent with 7% cash fee and warrants.
Expected close March 27, 2025; registration rights agreement requires filing by April 15, 2025.

item 1.01 item 2.03 item 3.02 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.